New US Treasury rules led to scrapping $160b Pfizer-Allergan merger

New US Treasury rules led to scrapping $160b Pfizer-Allergan merger

A company logo is seen through branches at a Pfizer office in Dublin, Ireland November 24, 2015. REUTERS/Cathal McNaughton

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter